Calculation
P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income attributable to Express Scripts1 (in thousands) |
÷ | No. shares of common stock outstanding2 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 27, 2018 | 9.82 | = | 78.64 | ÷ | 8.00 | 8.00 | = | 4,517,400 | ÷ | 564,347,000 | |
Feb 14, 2017 | 12.39 | = | 69.63 | ÷ | 5.62 | 5.62 | = | 3,404,400 | ÷ | 605,720,000 | |
Feb 16, 2016 | 18.52 | = | 68.65 | ÷ | 3.71 | 3.71 | = | 2,476,400 | ÷ | 668,046,000 | |
Feb 23, 2015 | 31.40 | = | 86.72 | ÷ | 2.76 | 2.76 | = | 2,007,600 | ÷ | 726,898,000 | |
Feb 20, 2014 | 32.44 | = | 77.12 | ÷ | 2.38 | 2.38 | = | 1,844,600 | ÷ | 776,032,000 | |
Feb 19, 2013 | 35.52 | = | 56.98 | ÷ | 1.60 | 1.60 | = | 1,312,900 | ÷ | 818,499,000 | |
Feb 22, 2012 | 19.62 | = | 51.63 | ÷ | 2.63 | 2.63 | = | 1,275,800 | ÷ | 484,778,000 | |
Feb 16, 2011 | 25.68 | = | 57.42 | ÷ | 2.24 | 2.24 | = | 1,181,200 | ÷ | 528,284,000 | |
Feb 24, 2010 | 29.19 | = | 43.88 | ÷ | 1.50 | 1.50 | = | 827,600 | ÷ | 550,596,000 | |
Feb 25, 2009 | 18.34 | = | 28.73 | ÷ | 1.57 | 1.57 | = | 776,100 | ÷ | 495,352,000 | |
Feb 21, 2008 | 28.83 | = | 32.38 | ÷ | 1.12 | 1.12 | = | 567,800 | ÷ | 505,616,000 | |
Feb 8, 2007 | 20.76 | = | 18.15 | ÷ | 0.87 | 0.87 | = | 474,400 | ÷ | 542,544,000 | |
Feb 23, 2006 | 32.42 | = | 22.15 | ÷ | 0.68 | 0.68 | = | 400,000 | ÷ | 585,484,088 |
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Express Scripts Holding Co. Annual Report.
- Share Price Trend
- The share price experienced notable fluctuations over the observed period. Initially, it declined from $22.15 in early 2006 to a low of $18.15 in early 2007. Subsequently, a significant increase was observed, reaching a peak of $57.42 by early 2011. After this peak, the share price exhibited some volatility but remained relatively high, frequently surpassing $50. Notably, there was a consistent upward movement from 2013 onwards, culminating in a value of $78.64 by early 2018.
- Earnings Per Share (EPS) Pattern
- EPS demonstrated a strong growth trajectory over the years. Starting at $0.68 in 2006, it more than doubled to $1.57 by early 2009. Despite a slight dip in 2010 to $1.50, EPS rebounded and generally increased thereafter, reaching $8.00 by early 2018. This pattern indicates an overall enhancement in profitability with intermittent periods of stabilization.
- Price-to-Earnings (P/E) Ratio Analysis
- The P/E ratio displayed considerable variability during the period. It began at a relatively high 32.42 in 2006, decreased to 18.34 in 2009, and spiked again to 35.52 in 2013. From 2013 onwards, the P/E ratio showed a declining trend, dropping to 9.82 by early 2018. This declining P/E, coupled with rising EPS, suggests that the company's earnings growth outpaced share price appreciation in the later years, potentially reflecting improved market valuation grounded in stronger financial performance.
- Overall Financial Insights
- Over the examined timeframe, the company displayed significant growth in earnings per share, supporting an appreciation in share price despite some intermediate fluctuations. The general decrease in the P/E ratio in later years, in conjunction with rising EPS, indicates that the stock became less expensive relative to earnings, which could imply enhanced investor confidence in the company's sustained profitability and value generation capabilities.
Comparison to Competitors
Express Scripts Holding Co. | Abbott Laboratories | CVS Health Corp. | Elevance Health Inc. | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|---|---|
Feb 27, 2018 | 9.82 | 220.29 | 10.69 | 15.44 | 70.95 | 29.96 | 20.77 |
Feb 14, 2017 | 12.39 | 55.16 | 14.91 | 17.48 | 37.16 | 33.17 | 21.73 |
Feb 16, 2016 | 18.52 | 12.83 | 18.98 | 12.99 | 34.24 | 40.56 | 18.18 |
Feb 23, 2015 | 31.40 | 31.30 | 24.64 | 15.29 | 44.77 | 20.75 | 18.50 |
Feb 20, 2014 | 32.44 | 23.25 | 17.71 | 9.95 | 22.82 | 14.99 | 12.35 |
Feb 19, 2013 | 35.52 | 9.24 | 16.23 | 7.09 | 35.05 | 10.57 | 10.58 |
Feb 22, 2012 | 19.62 | 18.67 | 16.66 | 8.36 | 39.05 | 13.37 | 10.78 |
Feb 16, 2011 | 25.68 | 15.68 | 13.20 | 8.74 | 33.85 | 12.65 | 10.01 |
Feb 24, 2010 | 29.19 | 14.69 | 12.70 | 5.53 | 54.30 | 17.11 | 9.91 |
Feb 25, 2009 | 18.34 | 17.11 | 11.72 | 8.26 | 21.99 | 26.02 | 11.66 |
Feb 21, 2008 | 28.83 | 23.82 | 22.10 | 12.02 | 79.87 | 20.81 | 12.85 |
Feb 8, 2007 | 20.76 | 48.17 | 19.24 | 16.05 | 58.08 | 21.31 | 17.58 |
Feb 23, 2006 | 32.42 | 20.03 | 20.64 | 20.66 | 36.68 | 35.12 | 24.20 |
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Sector (Health Care Equipment & Services)
Express Scripts Holding Co., P/E, long-term trends, comparison to sector (health care equipment & services)
Express Scripts Holding Co. | Health Care Equipment & Services | |
---|---|---|
Feb 27, 2018 | 9.82 | 23.75 |
Feb 14, 2017 | 12.39 | 24.26 |
Feb 16, 2016 | 18.52 | 19.90 |
Feb 23, 2015 | 31.40 | 22.12 |
Feb 20, 2014 | 32.44 | 15.59 |
Feb 19, 2013 | 35.52 | 11.51 |
Feb 22, 2012 | 19.62 | 14.53 |
Feb 16, 2011 | 25.68 | 12.68 |
Feb 24, 2010 | 29.19 | 12.01 |
Feb 25, 2009 | 18.34 | 14.94 |
Feb 21, 2008 | 28.83 | 18.27 |
Feb 8, 2007 | 20.76 | 22.40 |
Feb 23, 2006 | 32.42 | 23.69 |
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
Comparison to Industry (Health Care)
Express Scripts Holding Co. | Health Care | |
---|---|---|
Feb 27, 2018 | 9.82 | 30.93 |
Feb 14, 2017 | 12.39 | 21.47 |
Feb 16, 2016 | 18.52 | 19.50 |
Feb 23, 2015 | 31.40 | 21.56 |
Feb 20, 2014 | 32.44 | 18.62 |
Feb 19, 2013 | 35.52 | 15.80 |
Feb 22, 2012 | 19.62 | 15.84 |
Feb 16, 2011 | 25.68 | 15.00 |
Feb 24, 2010 | 29.19 | 11.75 |
Feb 25, 2009 | 18.34 | 12.99 |
Feb 21, 2008 | 28.83 | 19.44 |
Feb 8, 2007 | 20.76 | 18.63 |
Feb 23, 2006 | 32.42 | 21.68 |
Based on: 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).